Celltrion Pharm

068760.KQ

36.27 USD

0.21

+0.58%

Overview

Last close

36.27 usd

Market cap

1.58B usd

52 week high

93.83 usd

52 week low

30.18 usd

Target price

100.06 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

7.7989

Price/Book Value

5.3259

Enterprise Value

1.63B usd

EV/Revenue

4.4894

EV/EBITDA

34.1421

Key financials

Revenue TTM

202.13M usd

Gross Profit TTM

59.48M usd

EBITDA TTM

31.49M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

458.65M usd

Net debt

N/A usd

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea.